Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Tcr2 TherapeuticsGritstone OncologyCellular Biomedicine GroupHarpoon TherapeuticsCabaletta Bio
SymbolNASDAQ:TCRRNASDAQ:GRTSNASDAQ:CBMGNASDAQ:HARPNASDAQ:CABA
Price Information
Current Price$7.01$6.10$15.50$11.11$6.73
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$17.50$17.00$21.67$26.33$22.00
% Upside from Price Target149.64% upside178.69% upside39.78% upside137.02% upside226.89% upside
Trade Information
Market Cap$165.40 million$231.47 million$298.46 million$282.87 million$163.91 million
Beta1.561.412.020.92N/A
Average Volume97,187190,25975,89982,70370,596
Sales & Book Value
Annual RevenueN/A$4.36 million$340,000.00$5.78 millionN/A
Price / SalesN/A51.74882.1347.94N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$3.75 per share$2.89 per share$3.82 per shareN/A
Price / BookN/A1.635.362.91N/A
Profitability
Net Income$-24,250,000.00$-94,430,000.00$-49,980,000.00$-55,570,000.00N/A
EPS($4.62)($2.81)($2.63)($2.55)($4.07)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,163.41%N/A-962.70%N/A
Return on Equity (ROE)-26.16%-62.40%-67.21%-51.51%N/A
Return on Assets (ROA)-25.16%-47.41%-45.26%-35.05%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.16%N/A0.15%N/A
Current Ratio21.14%6.73%1.44%6.69%23.42%
Quick Ratio21.14%6.73%1.44%6.69%23.42%
Ownership Information
Institutional Ownership Percentage58.89%76.56%22.83%75.52%67.69%
Insider Ownership Percentage39.07%38.00%9.10%N/AN/A
Miscellaneous
Employees471131934512
Shares Outstanding24.08 million36.98 million19.35 million24.94 million24.03 million
Next Earnings Date5/11/2020 (Estimated)5/11/2020 (Estimated)5/5/2020 (Estimated)5/14/2020 (Estimated)6/29/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel